Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze NAMS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate NAMS investment potential.

What is NAMS stock price today?

Get real-time NAMS stock price, historical data, and price charts on Financhill. Track NAMS performance with our advanced analysis tools.

Is NAMS a good investment?

Evaluate NAMS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy NAMS stock?

To buy NAMS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of NAMS?

View detailed market capitalization data and company valuation metrics for NAMS on our comprehensive analysis page.

What is the P/E ratio of NAMS?

Use our fundamental analysis tools to view NAMS P/E ratio and compare valuation metrics with industry peers.

What are NAMS earnings?

View NAMS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

NewAmsterdam Pharma Co. NV Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

NAMS
NewAmsterdam Pharma Co. NV

Last Price:

$35.47

Seasonality Move:

-4.57%

7 Day Trial

ALL ACCESS PASS

$ 7

NewAmsterdam Pharma Co. NV Stock Forecast

Over the next 52 weeks, NewAmsterdam Pharma Co. NV has on average historically risen by 31.3% based on the past 5 years of stock performance.
NewAmsterdam Pharma Co. NV has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Is NewAmsterdam Pharma Co. NV Stock Undervalued?

The current NewAmsterdam Pharma Co. NV [NAMS] share price is $34.28. The Score for NAMS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
NAMS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will NewAmsterdam Pharma Co. NV Stock Go Up Next Year?

Over the next 52 weeks, NewAmsterdam Pharma Co. NV has on average historically risen by 31.3% based on the past 5 years of stock performance.

NewAmsterdam Pharma Co. NV Stock Rating

Buy

NewAmsterdam Pharma Co. NV (NAMS) is a Buy

Is NewAmsterdam Pharma Co. NV overpriced?

NewAmsterdam Pharma Co. NV has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

NewAmsterdam Pharma Co. NV Stock Price History

Is NAMS stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAMS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

Netherlands

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

newamsterdampharma.com

52-Week Data

52-Week High:

42.00

52-Week Low:

14.06

Prediction Charts

Market Cap:

3.9B

Price in USD:

34.28

Volume:

900.9K

Beta:

0.07

Technical Analysis

SMA50:

34.06

SMA100:

35.51

SMA200:

28.94

52-Wk Change:

73.92%

Stock Predictions

Is NewAmsterdam Pharma Co. NV stock public?

Yes, NewAmsterdam Pharma Co. NV is a publicly traded company.
What is the NewAmsterdam Pharma Co. NV stock quote today?

The NewAmsterdam Pharma Co. NV stock price is 34.28 USD today.
How to buy NewAmsterdam Pharma Co. NV stock online?

You can buy NewAmsterdam Pharma Co. NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Feb-6	32.78	34.30	34.74	32.15
Feb-9	34.37	35.00	35.22	33.40
Feb-10	34.95	34.89	35.61	34.58
Feb-11	35.11	34.24	35.11	33.14
Feb-12	34.26	34.86	35.62	34.11
Feb-13	35.22	34.63	35.82	34.29
Feb-17	35.26	35.24	35.55	34.47
Feb-18	35.29	35.76	37.76	34.95
Feb-19	35.56	34.63	35.77	33.51
Feb-20	34.38	35.58	36.00	34.00
Feb-23	34.89	36.17	36.26	34.57
Feb-24	36.11	36.01	36.61	35.43
Feb-25	36.13	35.01	36.88	34.56
Feb-26	35.00	34.28	35.00	33.24

NewAmsterdam Pharma Co. NV Earnings

NewAmsterdam Pharma Co. NV Earnings Report: Per Share NewAmsterdam Pharma Co. NV Earnings Q1 Q2 Q3 and Q4 last year and next year.

NewAmsterdam Pharma Co. NV Forecast Revenue Growth

NewAmsterdam Pharma Co. NV Stock Analysis: Historical quarterly revenues per share for NewAmsterdam Pharma Co. NV and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.43 per share, and an increase next year of $0.66 per share.

* NewAmsterdam Pharma Co. NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.